Related Experiment Videos
Biologicals and biological response modifiers: fourth modality of cancer treatment
Abstract:
Considerable progress has been made in the last 5 years toward the development of specific biological approaches to the treatment of cancer. The techniques of genetic engineering, mass cell culture, and improved techniques in protein and nucleic acid sequencing and synthesis have made available biologicals as specific, highly purified molecules that can be used in cancer therapy. While extensive clinical trials are needed to demonstrate that biologicals and biological response modifiers can provide a survival advantage for patients with cancer, the preliminary data indicate that these approaches can be useful in inducing responses in patients with clinically apparent disease. Further studies with these approaches in conjunction with surgery, radiotherapy, and chemotherapy should be helpful in definitively establishing biologicals and biological response modifiers as the fourth modality of cancer treatment.
Insights
Recent advancements in biological therapies, including genetic engineering and cell culture, offer promising new cancer treatments. These biologicals and biological response modifiers may soon become a fourth pillar of cancer care alongside traditional methods.
Area of Science:
- Oncology
- Biotechnology
- Molecular Biology
Background:
- Significant progress in cancer treatment development over the last 5 years.
- Emergence of specific biological approaches utilizing advanced biotechnology techniques.
Purpose of the Study:
- To review the development and potential of biologicals and biological response modifiers in cancer therapy.
- To assess the preliminary efficacy and future role of these novel treatments.
Main Methods:
- Leveraging techniques such as genetic engineering, mass cell culture, and advanced sequencing.
- Utilizing highly purified biological molecules for therapeutic applications.
Main Results:
- Preliminary data suggest biologicals can induce responses in patients with visible cancer.
- Extensive clinical trials are required to confirm survival benefits.
Conclusions:
- Biologicals and biological response modifiers show potential as a fourth modality in cancer treatment.
- Further research is needed to integrate these with surgery, radiotherapy, and chemotherapy for optimal outcomes.